Displacement-encoded and manganese-enhanced cardiac MRI reveal that nNOS, not eNOS, plays a dominant role in modulating contraction and calcium influx in the mammalian heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 2, 2012, Pages

  Vandsburger, Moriel H ^a   French, Brent A ^a   Kramer, Christopher M ^a   Zhong, Xiaodong ^b   Epstein, Frederick H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b SIEMENS CORPORATE RESEARCH   (United States)

Author keywords

Contractile function; Endothelial nitric oxide synthase; Magnetic resonance imaging; Neuronal nitric oxide synthase

Indexed keywords

ADENOSINE A2 RECEPTOR AGONIST; ATL 313; CALCIUM CHANNEL L TYPE; CARBACHOL; DOBUTAMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MANGANESE; NEURONAL NITRIC OXIDE SYNTHASE; NIFEDIPINE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY MASS; CALCIUM TRANSPORT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HEART CONTRACTION; HEART HEMODYNAMICS; HEART MUSCLE CELL; HEART RATE; HEART SCINTISCANNING; LOW DRUG DOSE; MALE; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION; SARCOPLASMIC RETICULUM; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD PRESSURE; CALCIUM; HEART; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, KNOCKOUT; MUSCLE CONTRACTION; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III;

EID: 84855301902     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00705.2011     Document Type: Article

References (58)

1. 2+]i transients in mouse ventricular myocytes. J Physiol 543: 889-898, 2002.
2. Ashley EA, Sears CE, Bryant SM, Watkins HC, Casadei B. Cardiac nitric oxide synthase 1 regulates basal and β-adrenergic contractility in murine ventricular myocytes. Circulation 105: 3011-3016, 2002.
3. Balligand JL. "La Donna e Mobile." Is cardiac neuronal nitric oxide synthase such a disconcerting enzyme? Circulation 112: 3668-3671, 2005.
4. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JAC, Berkowitz DE, Hare JM. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416: 337-339, 2002.
5. 2+ current is not altered in cardiac ventricular myocytes from mice lacking endothelial nitric oxide synthase. J Physiol 528: 279-289, 2000.
6. Berr SS, Roy RJ, French BA, Yang Z, Gilson W, Kramer CM, Epstein FH. Black blood gradient echo cine magnetic resonance imaging of the mouse heart. Mag Res Med 53: 1074-1079, 2005.
7. Bers DM. Calcium cycling and signaling in cardiac myocytes. Ann Rev Physiol 70: 23-49, 2008.
8. Burger DE, Lu X, Lei M, Xiang FL, Hammoud L, Jiang M, Wang H, Jones DL, Sims SM, Feng Q. Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice. Circulation 120: 1345-1354, 2009.
9. Casadei B. The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function. Exp Physiol 91: 943-955, 2006.
10. Champion HC, Georgakopoulos D, Takimoto E, Isoda T, Wang Y, Kass DA. Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3. Circ Res 94: 657-663, 2004.
11. Damy T, Ratajczak P, Shah AM, Camors E, Marty I, Hasenfuss G, Marotte F, Samuel JL, Heymes C. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 363: 1365-1367, 2004.
12. Danson EJ, Choate JK, Paterson DJ. Cardiac nitric oxide: emerging role for nNOS in regulating physiological function. Pharma & Ther 106: 57-74, 2005.
13. Dawson D, Lygate CA, Zhang MH, Hulbert K, Neubauer S, Casadei B. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation 112: 3729-3737, 2005.
14. Dhalla AK, Wong MY, Wang WQ, Biaggioni I, Belardinelli L. Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats. J Pharma Exp Thera 316: 695-702, 2006.
15. Epstein FH. MR in mouse models of cardiac disease. NMR in Biomedicine 20: 238-255, 2007.
16. Gilson WD, Epstein FH, Yang Z, Xu Y, Prasad KMR, Toufektsian MC, Laubach VE, French BA. Borderzone contractile dysfunction is transiently attenuated and left ventricular structural remodeling is markedly reduced following reperfused myocardial infarction in inducible nitric oxide synthase knockout mice. J Am Col Cardio 50: 1799-1807, 2007.
17. Godecke A, Heinicke T, Andreij K, Kiseleva I, Strasser RH, Decking UK, Stumpe T, Isenberg G, Schrader J. Inotropic response to betaadrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts. J Physiol 532: 195-204, 2001.
18. Gonzalez DR, Beigi F, Treuer AV, Hare JM. Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. Proc Nat Acad Sci 104: 20612-20617, 2007.
19. Gyurko R, Kuhlencordt P, Fishman MC, Huang PL. Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol Heart Circ Physiol 278: H971-H981, 2000.
20. Han X, Kubota I, Feron O, Opel DJ, Arstall MA, Zhao YY, Huang P, Fishman MC, Michel T, Kelly RA. Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Nat Acad Sci 95: 6510-6515, 1998.
21. Hare JM. Nitric oxide and excitation-contraction coupling. J Mol Cell Cardiol 35: 719-729, 2003.
22. Hove-Madsen L, Prat-Vidal C, Llach A, Ciruela F, Casado V, Lluis C, Bayes-Genis A, Cina J, Franco R. Adenosine A2a receptors are expressed in human atrial myocytes and modulate spontaneous sarcoplasmic reticulum calcium release. Cardiovasc Res 72: 292-302, 2006.
23. Hu T, Chuang K, Yanasak N, Koretsky A. Relationship between blood and myocardium manganese levels during manganese-enhanced MRI (MEMRI) with T1 mapping in rats. NMR Biomed 24: 46-53, 2010.
24. Hu TCC, Pautler RG, MacGowan GA, Koretsky AP. Manganeseenhanced MRI of mouse heart during changes in inotropy. Mag Res Med 46: 884-890, 2001.
25. Hunter DR, Haworth RA, Berkoff HA. Cellular manganese uptake by the isolated perfused rat heart: a probe for the sarcolemma calcium channel. J Mol Cell Cardiol 13: 823-832, 1981.
26. Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch KD. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res 94: 1256-1262, 2004.
27. Khan SA, Skaf MW, Harrison RW, Lee K, Minhas KM, Kumar A, Fradley M, Shoukas AA, Berkowitz DE, Hare JM. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res 92: 1322-1329, 2003.
28. Kim D, Gilson WD, Kramer CM, Epstein FH. Myocardial tissue tracking with two-dimensional cine displacement-encoded MR imaging: development and initial evaluation. Radiology 230: 862-871, 2004.
29. Martin SR, Emanuel K, Sears CE, Zhang YH, Casadei B. Are myocardial eNOS and nNOS involved in the β-adrenergic and muscarinic regulation of inotropy? A systematic investigation. Cardiovasc Res 70: 97-106, 2006.
30. Massion PB, Feron O, Dessy C, Balligand JL. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93: 388-398, 2003.
31. Masumiya H, Tsujikawa H, Hino N, Ochi R. Modulation of manganese currents by 1,4-dihydropyridines, isoproterenol, and foskolin in rabbit ventricular cells. Pflügers Archiv Euro J Physiol 446: 695-701, 2003.
32. 2+ release in cardiomyocytes. Nat Cell Biol 3: 867-873, 2001.
33. Saraiva RM, Minhas KM, Raju SVY, Barouch LA, Pitz E, Schuleri KH, Vandegaer K, Li D, Hare JM. Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium. Circulation 112: 3415-3422, 2005.
34. Scherrer-Crosbie M, Ullrich R, Bloch KD, Nakajima H, Nasseri B, Aretz HT, Lindsey ML, Vancon AC, Huang PL, Lee RT, Zapol WM, Picard MH. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 104: 1286-1291, 2001.
35. Sears C, Choate J, Paterson D. NO-cGMP pathway accentuates the decrease in heart rate caused by cardiac vagal nerve stimulation. J App Physiol 86: 510-516, 1999.
36. Sears CE, Bryant SM, Ashley EA, Lygate CA, Rakovic S, Wallis HL, Neubauer S, Terrar DA, Casadei B. Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ Res 92: e52-e59, 2003.
37. Shen J, Jiang B, Pappano A. Comparison of L-type calcium channel blockade by nifedipine and/or cadmium in guinea pig ventricular myocytes. Pharmacol Exp Ther 294: 562-570, 2000.
38. Silberman GA, Fan THM, Liu H, Jiao Z, Xiao HD, Lovelock JD, Boulden BM, Widder J, Fredd S, Bernstein KE, Wolska BM, Dikalov S, Harrison DG, Dudley SC Jr. Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation 121: 519-528, 2010.
39. Slawson S, Roman B, Williams D, Koretsky A. Cardiac MRI of the normal and hypertrophied mouse heart. Mag Res Med 39: 980-987, 1998.
40. Spottiswoode B, Zhong X, Hess A, Kramer C, Meintjes E, Mayosi B, Epstein F. Tracking myocardial motion from cine DENSE images using spatiotemporal phase unwrapping and temporal fitting. IEEE Trans Med Imag 26: 15-30.
41. Spottiswoode BS, Zhong X, Lorenz CH, Mayosi BM, Meintjes EM, Epstein FH. Motion-guided segmentation for cine DENSE MRI. Med Image Anal 13: 105-115, 2009.
42. Stoyanovsky D, Murphy T, Anno PR, Kim YM, Salama G. Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 21: 19-29, 1997.
43. Sun J, Morgan M, Shen RF, Steenbergen C, Murphy E. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res 101: 1155-1163, 2007.
44. Van den Bergh A, Flameng W, Herijgers P. Parameters of ventricular contractility in mice: influence of load and sensitivity to changes in inotropic state. Pflügers Archiv Euro J Physiol 455: 987-994, 2008.
45. Vandecasteele G, Eschenhagen T, Scholz H, Stein B, Verde I, Fischmeister R. Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nat Med 5: 331-334, 1999.
46. Vandsburger M, Epstein F. Emerging MRI methods in translational cardiovascular research. J Cardio Trans Res 4: 477-492, 2011.
47. Vandsburger MH, French BA, Helm PA, Roy RJ, Kramer CM, Young AA, Epstein FH. Multi-parameter in vivo cardiac magnetic resonance imaging demonstrates normal perfusion reserve despite severely attenuated β-adrenergic functional response in neuronal nitric oxide synthase knockout mice. Euro Heart J 28: 2792-2798, 2007.
48. Vila-Petroff MG, Younes A, Egan J, Lakatta EG, Sollott SJ. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 84: 1020-1031, 1999.
49. Wang H, Kohr MJ, Traynham CJ, Wheeler DG, Janssen PML, Ziolo MT. Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban. Am J Physiol Cell Physiol 294: C1566-C1575, 2008.
50. 2+ current. Am J Physiol Heart Circ Physiol 294: H1473-H1480, 2008.
51. Xu KY, Huso DL, Dawson TM, Bredt DS, Becker LC. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Nat Acad Sci 96: 657-662, 1999.
52. Xu L, Eu JP, Meissner G, Stamler JS. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279: 234-237, 1998.
53. Zhang YH, Zhang MH, Sears CE, Emanuel K, Redwood C, El-Armouche A, Kranias EG, Casadei B. Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase-deficient mice. Circ Res 102: 242-249, 2008.
54. Zhong J, Yu X. Strain and torsion quantification in mouse hearts under dobutamine stimulation using 2D multiphase MR DENSE. Mag Res Med 64: 1315-1322, 2010.
55. Zhong X, Helm P, Epstein F. Balanced multipoint displacement encoding for DENSE MRI. Mag Res Med 61: 981-988, 2009.
56. Ziolo MT. The fork in the nitric oxide road: cyclic GMP or nitrosylation? Nitric Oxide 18: 153-156, 2008.
57. Ziolo MT, Bers DM. The real estate of NOS signaling: location, location, location. Circ Res 92: 1279-1281, 2003.
58. 2+ transients. Circulation 109: 1886-1891, 2004.